Key Highlights
• Nasdaq-100 Index Addition: Astera Labs joined the Nasdaq-100 Index on June 22, triggering passive fund buying from index-tracking funds.
• Major Analyst Price Target Increases: Stifel Nicolaus raised its target to $460 and Bank of America lifted its target to $450.
• Record Q1 Revenue Growth: Q1 revenue surged 93.5% year-over-year to a record $308.4 million with 76% gross margins, backed by a seven-year Amazon deal.
Astera Labs (NASDAQ: ALAB) surged to near its 52-week high, propelled by a confluence of catalysts: its recent addition to the Nasdaq-100 Index on June 22 triggered passive fund buying, while a broad tech rally was fueled by a US-Iran ceasefire agreement easing Strait of Hormuz tensions and lifting risk appetite.
Stifel Nicolaus raised its price target to $460 and Bank of America lifted its target to $450, reflecting growing Wall Street conviction in Astera's dominant position supplying AI connectivity hardware, a critical and rapidly growing segment of the broader AI infrastructure buildout.
The conviction stems in part from a seven-year deal with Amazon (NASDAQ: AMZN), a significant long-term commercial relationship that provides meaningful revenue visibility for the company over an extended time horizon.
This came after Q1 revenue surged 93.5% year-over-year to a record $308.4 million with 76% gross margins, an exceptionally strong combination of rapid growth and high profitability that has reinforced bullish analyst sentiment across multiple research firms.
Shares extended gains with an additional 9% increase in a subsequent session, underscoring sustained investor enthusiasm for Astera's positioning as a key beneficiary of the broader AI connectivity hardware investment cycle.
()


_11_03_2026_13_33_17_904664.jpg)



Please wait processing your request...